ANGPT2 and NOS3 polymorphisms and clinical outcome in advanced hepatocellular carcinoma patients receiving sorafenib

G. Marisi; E. Petracci; F. Raimondi; L. Faloppi; F.G. Foschi; G. Lauletta; M. Iavarone; M. Canale; M. Valgiusti; L.M. Neri; P. Ulivi; G. Orsi; G. Rovesti; R. Vukotic; F. Conti; A. Cucchetti; G. Ercolani; K. Andrikou; S. Cascinu; M. Scartozzi; A. Casadei-Gardini

doi:10.3390/cancers11071023

ANGPT2 and NOS3 polymorphisms and clinical outcome in advanced hepatocellular carcinoma patients receiving sorafenib

G. Marisi, E. Petracci, F. Raimondi, L. Faloppi, F.G. Foschi, G. Lauletta, M. Iavarone, M. Canale, M. Valgiusti, L.M. Neri, P. Ulivi, G. Orsi, G. Rovesti, R. Vukotic, F. Conti, A. Cucchetti, G. Ercolani, K. Andrikou, S. Cascinu, M. ScartozziA. Casadei-Gardini

Research output: Contribution to journal › Article

Original language	Italian
Journal	Cancers
Volume	11
Issue number	7
DOIs	https://doi.org/10.3390/cancers11071023
Publication status	Published - 2019

Cite this

Marisi, G., Petracci, E., Raimondi, F., Faloppi, L., Foschi, F. G., Lauletta, G., Iavarone, M., Canale, M., Valgiusti, M., Neri, L. M., Ulivi, P., Orsi, G., Rovesti, G., Vukotic, R., Conti, F., Cucchetti, A., Ercolani, G., Andrikou, K., Cascinu, S., ... Casadei-Gardini, A. (2019). ANGPT2 and NOS3 polymorphisms and clinical outcome in advanced hepatocellular carcinoma patients receiving sorafenib. Cancers, 11(7). https://doi.org/10.3390/cancers11071023

ANGPT2 and NOS3 polymorphisms and clinical outcome in advanced hepatocellular carcinoma patients receiving sorafenib. / Marisi, G.; Petracci, E.; Raimondi, F.; Faloppi, L.; Foschi, F.G.; Lauletta, G.; Iavarone, M.; Canale, M.; Valgiusti, M.; Neri, L.M.; Ulivi, P.; Orsi, G.; Rovesti, G.; Vukotic, R.; Conti, F.; Cucchetti, A.; Ercolani, G.; Andrikou, K.; Cascinu, S.; Scartozzi, M.; Casadei-Gardini, A.

In: Cancers, Vol. 11, No. 7, 2019.

Research output: Contribution to journal › Article

Marisi, G, Petracci, E , Raimondi, F, Faloppi, L, Foschi, FG, Lauletta, G, Iavarone, M, Canale, M, Valgiusti, M, Neri, LM, Ulivi, P, Orsi, G, Rovesti, G, Vukotic, R, Conti, F, Cucchetti, A, Ercolani, G, Andrikou, K, Cascinu, S, Scartozzi, M & Casadei-Gardini, A 2019, 'ANGPT2 and NOS3 polymorphisms and clinical outcome in advanced hepatocellular carcinoma patients receiving sorafenib', Cancers, vol. 11, no. 7. https://doi.org/10.3390/cancers11071023

Marisi, G. ; Petracci, E. ; Raimondi, F. ; Faloppi, L. ; Foschi, F.G. ; Lauletta, G. ; Iavarone, M. ; Canale, M. ; Valgiusti, M. ; Neri, L.M. ; Ulivi, P. ; Orsi, G. ; Rovesti, G. ; Vukotic, R. ; Conti, F. ; Cucchetti, A. ; Ercolani, G. ; Andrikou, K. ; Cascinu, S. ; Scartozzi, M. ; Casadei-Gardini, A. / ANGPT2 and NOS3 polymorphisms and clinical outcome in advanced hepatocellular carcinoma patients receiving sorafenib. In: Cancers. 2019 ; Vol. 11, No. 7.

@article{5c8eb3d83e274a40ae116eac2eccf90d,

title = "ANGPT2 and NOS3 polymorphisms and clinical outcome in advanced hepatocellular carcinoma patients receiving sorafenib",

author = "G. Marisi and E. Petracci and F. Raimondi and L. Faloppi and F.G. Foschi and G. Lauletta and M. Iavarone and M. Canale and M. Valgiusti and L.M. Neri and P. Ulivi and G. Orsi and G. Rovesti and R. Vukotic and F. Conti and A. Cucchetti and G. Ercolani and K. Andrikou and S. Cascinu and M. Scartozzi and A. Casadei-Gardini",

note = "Cited By :2 Export Date: 25 February 2020",

year = "2019",

doi = "10.3390/cancers11071023",

language = "Italian",

volume = "11",

journal = "Cancers",

issn = "2072-6694",

publisher = "MDPI AG",

number = "7",

}

TY - JOUR

T1 - ANGPT2 and NOS3 polymorphisms and clinical outcome in advanced hepatocellular carcinoma patients receiving sorafenib

AU - Marisi, G.

AU - Petracci, E.

AU - Raimondi, F.

AU - Faloppi, L.

AU - Foschi, F.G.

AU - Lauletta, G.

AU - Iavarone, M.

AU - Canale, M.

AU - Valgiusti, M.

AU - Neri, L.M.

AU - Ulivi, P.

AU - Orsi, G.

AU - Rovesti, G.

AU - Vukotic, R.

AU - Conti, F.

AU - Cucchetti, A.

AU - Ercolani, G.

AU - Andrikou, K.

AU - Cascinu, S.

AU - Scartozzi, M.

AU - Casadei-Gardini, A.

N1 - Cited By :2 Export Date: 25 February 2020

PY - 2019

Y1 - 2019

U2 - 10.3390/cancers11071023

DO - 10.3390/cancers11071023

M3 - Articolo

VL - 11

JO - Cancers

JF - Cancers

SN - 2072-6694

IS - 7

ER -

Access to Document

10.3390/cancers11071023

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85070521953&doi=10.3390%2fcancers11071023&partnerID=40&md5=ca128f53a0915959e8d603ab7dc31b55

Projects

Istituto Scientifico Romagnolo - MEDICINA DI PRECISIONE, GENERE, ETNIA E "GEROSCIENCE": MECCANISMI GENETICO- MOLECOLARI NELLO SVILUPPO, CARATTERIZZAZIONE E TERAPIA DEI TUMORI

Project: Other project

ANGPT2 and NOS3 polymorphisms and clinical outcome in advanced hepatocellular carcinoma patients receiving sorafenib

Cite this

Access to Document

Related content

Projects

Istituto Scientifico Romagnolo - MEDICINA DI PRECISIONE, GENERE, ETNIA E "GEROSCIENCE": MECCANISMI GENETICO- MOLECOLARI NELLO SVILUPPO, CARATTERIZZAZIONE E TERAPIA DEI TUMORI